77 related articles for article (PubMed ID: 24616160)
1. Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA.
Duployez N; Nibourel O; Marceau-Renaut A; Willekens C; Helevaut N; Caillault A; Villenet C; Celli-Lebras K; Boissel N; Jourdan E; Dombret H; Figeac M; Preudhomme C; Renneville A
Am J Hematol; 2014 Jun; 89(6):610-5. PubMed ID: 24616160
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of dynamic monitoring of RUNX1-RUNX1T1 transcript in pediatric acute myeloid leukemia].
Gao HT; Zhang Y; Sun K; Guo JM; Chen YQ; Chen XL; Shi J; Niu XN; Wang F; Huo L
Zhonghua Xue Ye Xue Za Zhi; 2017 Mar; 38(3):210-215. PubMed ID: 28395444
[No Abstract] [Full Text] [Related]
3. Single-cell RNA-seq reveals novel immune-associated biomarkers for predicting prognosis in AML patients with RUNX1::RUNX1T1.
Li XP; Dai Y; Zhang WN; Pan MM; Mao J; Zhao B; Jiang L; Gao Y
Int Immunopharmacol; 2023 Dec; 125(Pt B):111178. PubMed ID: 37951201
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of KIT mutant transcript levels for monitoring measurable residual disease in t (8;21) acute myeloid leukemia.
Sun Y; Wang X; Chen WM; Hao Y; Li LD; Li JY; Sun K; Shi ZY; Jiang H; Jiang Q; Huang XJ; Qin YZ
Hematol Oncol; 2024 Mar; 42(2):e3264. PubMed ID: 38461410
[TBL] [Abstract][Full Text] [Related]
5. [The study of clinical characteristics and prognosis of RUNX1-RUNX1T1 positive acute myeloid leukemia based on next-generation sequencing].
Wang YL; Gao SJ; Su L; Liu YJ; Zhang YW; Du YZ
Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):851-854. PubMed ID: 38049338
[No Abstract] [Full Text] [Related]
6. Trinh BQ, Ummarino S, Zhang Y, et al. Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML. Blood. 2021;138(15):1331-1344.
Blood; 2023 May; 141(20):2542. PubMed ID: 37200056
[No Abstract] [Full Text] [Related]
7. Not only mutations but also tumorigenesis can be substantially attributed to DNA damage from reactive oxygen species in RUNX1::RUNX1T1-fusion-positive acute myeloid leukemia.
Mandell JD; Fisk JN; Cyrenne E; Xu ML; Cannataro VL; Townsend JP
Leukemia; 2022 Dec; 36(12):2931-2933. PubMed ID: 36369483
[No Abstract] [Full Text] [Related]
8. KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX1::RUNX1T1.
Srinivasan S; Dhamne C; Patkar N; Chatterjee G; Moulik NR; Chichra A; Pallath A; Tembhare P; Shetty D; Subramanian PG; Narula G; Banavali S
Pediatr Blood Cancer; 2024 Feb; 71(2):e30791. PubMed ID: 38014874
[TBL] [Abstract][Full Text] [Related]
9. [An interlaboratory comparison study on the detection of RUNX1-RUNX1T1 fusion transcript levels and WT1 transcript levels].
Qin YZ; Zhu LW; Lin S; Geng SX; Liu SW; Cheng H; Wu CY; Xiao M; Li XQ; Hu RP; Wang LL; Liu HY; Ma DX; Guan T; Ye YX; Niu T; Cen JN; Lu LS; Sun L; Yang TH; Wang YG; Li T; Wang Y; Li QH; Zhao XS; Li LD; Chen WM; Long LY; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):889-894. PubMed ID: 31856435
[No Abstract] [Full Text] [Related]
10. Functional characterization of cooperating MGA mutations in RUNX1::RUNX1T1 acute myeloid leukemia.
Thomas ME; Qi W; Walsh MP; Ma J; Westover T; Abdelhamed S; Ezzell LJ; Rolle C; Xiong E; Rosikiewicz W; Xu B; Loughran AJ; Pruett-Miller SM; Janke LJ; Klco JM
Leukemia; 2024 May; 38(5):991-1002. PubMed ID: 38454121
[TBL] [Abstract][Full Text] [Related]
11. Fusion Gene-Based Classification of Variant Cytogenetic Rearrangements in Acute Myeloid Leukemia.
Gudipati M; Butler M; Koka R; Baer MR; Ning Y
Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833323
[TBL] [Abstract][Full Text] [Related]
12. RUNX1::RUNX1T1 Acute Myeloid Leukemia Cytogenetically Showing t(6;8)(p23;q22).
Higuchi A; Iriyama N
Cureus; 2024 Mar; 16(3):e56342. PubMed ID: 38633925
[TBL] [Abstract][Full Text] [Related]
13. A novel gene fusion RUNX1/ZNF423 promotes leukemic relapse of NUP98-rearranged AML.
Du W; Xia Z; Luo Z; Chen Y; Bing S; Wang W; Zhang X; Zhou Z; Zhang J; Cao J; Yang B; He Q; Shao X; Xu X; Ying M
Leukemia; 2023 Nov; 37(11):2286-2291. PubMed ID: 37714925
[No Abstract] [Full Text] [Related]
14. Combination of eriocalyxin B and homoharringtonine exerts synergistic anti-tumor effects against t(8;21) AML.
Lei YC; Chen XJ; Dai YT; Dai B; Wang JY; Li MH; Liu P; Liu H; Wang KK; Jiang L; Chen B
Acta Pharmacol Sin; 2024 Mar; 45(3):633-645. PubMed ID: 38017299
[TBL] [Abstract][Full Text] [Related]
15. Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia.
Eriksson A; Engvall M; Mathot L; Österroos A; Rippin M; Cavelier L; Ladenvall C; Baliakas P
Clin Cancer Res; 2023 Aug; 29(15):2826-2834. PubMed ID: 37022349
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of next-generation sequencing for measurable residual disease monitoring in three major fusion transcript subtypes of B-precursor acute lymphoblastic leukaemia.
Huang YJ; Chen SH; Liu HC; Jaing TH; Yeh TC; Kuo MC; Lin TL; Chen CC; Wang SC; Chang TK; Hsiao CC; Liang DC; Shih LY
Pathology; 2024 Apr; ():. PubMed ID: 38719770
[TBL] [Abstract][Full Text] [Related]
17. Functional Characterization of Cooperating MGA Mutations in RUNX1::RUNX1T1 Acute Myeloid Leukemia.
Klco J; Thomas M; Qi W; Walsh M; Ma J; Westover T; Abdelhamed S; Ezzell L; Rolle C; Xiong E; Rosikiewicz W; Xu B; Pruett-Miller S; Loughran A; Janke L
Res Sq; 2023 Sep; ():. PubMed ID: 37790524
[TBL] [Abstract][Full Text] [Related]
18. CSF3R T618I Collaborates With RUNX1-RUNX1T1 to Expand Hematopoietic Progenitors and Sensitizes to GLI Inhibition.
Swoboda AS; Arfelli VC; Danese A; Windisch R; Kerbs P; Redondo Monte E; Bagnoli JW; Chen-Wichmann L; Caroleo A; Cusan M; Krebs S; Blum H; Sterr M; Enard W; Herold T; Colomé-Tatché M; Wichmann C; Greif PA
Hemasphere; 2023 Oct; 7(10):e958. PubMed ID: 37841755
[TBL] [Abstract][Full Text] [Related]
19. RUNX1 and inv(16) are frenemies in AML.
Rao S
Blood; 2020 Nov; 136(21):2361-2362. PubMed ID: 33211836
[TBL] [Abstract][Full Text] [Related]
20. Standardization of Molecular MRD Levels in AML Using an Integral Vector Bearing ABL and the Mutation of Interest.
Nachmias B; Krichevsky S; Gatt ME; Gross Even-Zohar N; Shaulov A; Haran A; Aumann S; Vainstein V
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
